Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Do Hedge Funds Love AEterna Zentaris Inc. (USA) (AEZS)?

As we already know from media reports and hedge fund investor letters, many hedge funds lost money in the third quarter, blaming macroeconomic conditions and unpredictable events that hit several sectors, with healthcare among them. Nevertheless, most investors decided to stick to their bullish theses and their long-term focus allows us to profit from the recent declines. In particular, let’s take a look at what hedge funds think about AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) in this article.

AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) was in 4 hedge funds’ portfolios at the end of September. AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) investors should be aware of an increase in activity from the world’s largest hedge funds recently. There were 2 hedge funds in our database with AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) positions at the end of the previous quarter. The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity, but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as EnteroMedics Inc (NASDAQ:ETRM), Biodel Inc (NASDAQ:BIOD), and Rubicon Technology, Inc. (NASDAQ:RBCN) to gather more data points.

Follow Aeterna Zentaris Inc (NASDAQ:AEZS)
Trade (NASDAQ:AEZS) Now!

If you’d ask most traders, hedge funds are viewed as worthless, old financial tools of yesteryear. While there are over 8000 funds in operation today, our experts hone in on the elite of this group, around 700 funds. These investment experts have their hands on the bulk of the smart money’s total capital, and by watching their best investments, Insider Monkey has spotted a number of investment strategies that have historically beaten Mr. Market. Insider Monkey’s small-cap hedge fund strategy outpaced the S&P 500 index by 12 percentage points per year for a decade in their back tests.

Now, we’re going to take a look at the recent action surrounding AEterna Zentaris Inc. (USA) (NASDAQ:AEZS).

What have hedge funds been doing with AEterna Zentaris Inc. (USA) (NASDAQ:AEZS)?

At the end of the third quarter, a total of 4 of the hedge funds tracked by Insider Monkey were long this stock, an increase of 100% from one quarter earlier. With the smart money’s sentiment swirling, there exists an “upper tier” of key hedge fund managers who were increasing their holdings substantially (or already accumulated large positions).

Of the funds tracked by Insider Monkey, Renaissance Technologies has the biggest position in AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), worth close to $1 million, comprising less than 0.1% of its total 13F portfolio. On Renaissance Technologies’ heels is Sander Gerber of Hudson Bay Capital Management, with a $0.1 million position; the fund has less than 0.1% of its 13F portfolio invested in the stock. Remaining professional money managers that are bullish contain Ken Griffin’s Citadel Investment Group, and John Overdeck and David Siegel’s Two Sigma Advisors.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.